RxDoctor Payments Data

Robert Poehl, PA

Physician Assistant · Grant, MINPI 1710914650

Payments from drug & device makers

$445in general payments, 2019–2025

Across 20 payments — averaging $22.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$113
  • Johnson & Johnson$68
  • Otsuka America Pharmaceutical, Inc.$62
  • Braeburn Inc.$56
  • E.r. Squibb & Sons, L.L.C.$34
  • AbbVie$32
  • plus $81 from 4 others

What the payments were for

  • Food & beverage$445100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$445 in reported general payments places this provider in the 60th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$15,793
Medicare patients
48
Services billed
194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate86$283,583
Abilify MaintenaAripiprazole57$150,512
RexultiBrexpiprazole80$123,550
VraylarCariprazine Hcl36$49,012
VyvanseLisdexamfetamine Dimesylate67$26,438
GeodonZiprasidone Hcl12$20,685
TrintellixVortioxetine Hydrobromide40$19,908
Paliperidone ErPaliperidone92$19,370
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl38$10,763
FanaptIloperidone12$10,713
Lurasidone Hcl55$7,952
Olanzapine173$7,374
Aripiprazole183$5,832
Divalproex Sodium ErDivalproex Sodium107$5,710
Clozapine176$5,608

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$68$283,58386 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$62$274,061137 claims
AbbVieVraylar, Fetzima$32$53,59347 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Grant

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →